Infusion Therapy Market Analysis, Size, Trends | China | 2018-2024 | MedSuite (Includes 5 Reports)

  • Year: 2018
  • Scope: 2014-2024
  • Region: China
  • Pages: 245
  • Published Date: 06/03/2018
  • Type: MedSuite

From 2009 to 2011, the government of China invested $124 billion into the healthcare system. The emphasis of the 2010 healthcare reform was on health plan coverage and geographic healthcare availability, resulting in service expenditures per visit increasing 23% in outpatient and 28% in inpatient costs between 2010 and 2014, drug expenditures decreasing by 8% and 15% in outpatient and inpatient care and service expenditures increasing by 6% in outpatient care and by 13.1% in inpatient care per visit. While the reform has put additional pressure on providing basic care, compared to long-term advanced care, it concentrated resources to use more infusion therapy methods for a larger number of acute cases.

The total China infusion therapy market is growing at a rate of 6.1%, which will take the 2017 market value of $789.2 million up to $1.2 billion by 2024.

While this report suite contains all China infusion therapy market data, each of the market segments are also available as stand alone MedCore reports. This allows you to get access to only the infusion therapy market research that you need. You can view all these included reports and segmentation here:

  • Infusion Therapy Market Overview – MedView – Gives an easily accessible view of all infusion therapy device markets and trends and aggregates the data together for a picture of the total China market.
  • Product Portfolio for Infusion Therapy Devices – MedFolio – Covering all segmentation within this infusion therapy devices suite, we include insight on all available products in each market, any recalls and clinical trials.
  • Infusion Pump Market – MedCore –  Further segmented into Large Volume, Syringe, Patient Controlled Analgesia, Electronic Ambulatory and Disposable Infusion Pumps.
  • Intravenous Sets Market – MedCore – Covers segmentation on Dedicated Primary IV Sets, Secondary IV Sets, IV Extension Sets, and Gravity Sets
  • Needleless Connectors Market – MedCore – Segmented by valve type: Split Septum & Blunt Cannula NLC Market and Mechanical Valve NLC Market
  • Stopcock Market – MedCore –  Stopcocks are valves which turn the flow of certain parts of the IV line on and off, allowing for simultaneous medication flow and mixing before entering the catheter and for managing the sequence of medication administration.
  • Blood Transfusion Sets Market – MedCore –  Blood collection IV sets are short, connected to an IV bag and equipped with a thick intravenous needle for use in blood transfusion procedures.
  • OTHER INFORMATION – Company Profiles and SWOT, Disease Overviews, & Related Press Releases from Top Competitors

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More


  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2024, and Historical Data to 2014
  • Market Drivers & Limiters for Each Infusion Therapy Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors


Infusion therapy devices, produced under recognized international brands, compete in China’s market with clusters of local manufacturers, which control a vast majority of the market. In making purchasing decisions, hospitals consider cost a priority.

In this report suite we’ve analyzed several companies, which include Mindray, Becton Dickinson, Shandong Weigao and Others.

The "China Report Suite for Infusion Therapy Devices 2018 - MedSuite" includes analysis on the following companies currently active in this market:
B. Braun
CareFusion (Becton Dickinson)
Hospira (ICU Medical)
Smiths Medical
Fresenius Kabi
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology